amikacin has been researched along with triclosan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chiriano, G; Cosson, P; Harrison, CF; Hilbi, H; Kicka, S; Kranjc, A; Ouertatani-Sakouhi, H; Patthey-Vuadens, O; Perozzo, R; Perron, K; Scapozza, L; Scrignari, T; Slepikas, L; Soldati, T; Tarasevicius, E; Tardy, S | 1 |
2 other study(ies) available for amikacin and triclosan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enterococcus faecalis; Legionella pneumophila; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium marinum; Oxidoreductases; Pseudomonas aeruginosa; Rhodanine; Structure-Activity Relationship | 2016 |